LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
Copyright: © 2020, Yeboah et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License. Despite advances in identifying the key immunoregulatory roles of many of the human leukocyte immunoglobulin-like receptor (LILR) family members, t...
Main Authors: | Yeboah, Muchaala, Papagregoriou, Charys, Jones, Des C, Chan, HT Claude, Hu, Guangan, McPartlan, Justine S, Schiött, Torbjörn, Mattson, Ulrika, Mockridge, C Ian, Tornberg, Ulla-Carin, Hambe, Björn, Ljungars, Anne, Mattsson, Mikael, Tews, Ivo, Glennie, Martin J, Thirdborough, Stephen M, Trowsdale, John, Frendeus, Björn, Chen, Jianzhu, Cragg, Mark S, Roghanian, Ali |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2021
|
Online Access: | https://hdl.handle.net/1721.1/134054 |
Similar Items
-
Human leukocyte immunoglobulin-like receptors in health and disease
by: Silvia Redondo-García, et al.
Published: (2023-11-01) -
The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to <it>Salmonella </it>infection
by: Buerki Robin A, et al.
Published: (2009-10-01) -
The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells.
by: Young, N, et al.
Published: (2008) -
Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes
by: Anne Ljungars, et al.
Published: (2019-07-01) -
217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
by: Edward Stack, et al.
Published: (2020-11-01)